-

OMNIVISION Announces Patent Litigation Victory Against VisionX Technologies, LLC

OMNIVISION’s policy against paying non-practicing entities for meritless patent assertions results in another total victory

SANTA CLARA, Calif.--(BUSINESS WIRE)--OMNIVISION today announced another litigation victory upon the entry of final judgment of non-infringement in a lawsuit filed by non-practicing entity (“NPE”) VisionX Technologies, LLC (“VisionX”). OMNIVISION paid nothing to VisionX to resolve the matter.

“OMNIVISION is pleased to set another example of our unwavering commitment to defend against groundless NPE lawsuits,” said Robert Cleary, General Counsel of OMNIVISION and former patent litigator. “VisionX is the latest NPE to fail. They attempted to advance nonsensical claim construction arguments as cover for unsupportable infringement positions. In the end, we called their bluff as we always do with NPEs, and VisionX agreed to a final judgment of non-infringement for all claims.”

In this case, VisionX asserted three patents that it acquired from a broker. Despite glaring holes in the infringement arguments for all three patents, as highlighted by OMNIVISION’s focused and persistent motion practice, VisionX pressed forward to try to pressure OMNIVISION into paying to make the case go away. Facing exposure to possible attorneys’ fees, VisionX ultimately conceded, and OMNIVISION prevailed with a full victory and final judgment of non-infringement as to all three asserted patents – just days before the claim construction hearing.

This is OMNIVISION’s fourth complete victory against an NPE in as many years, with prior wins against Cedar Lane Technologies Inc., ID Image Sensing LLC (Acacia) and Bell Semiconductor, LLC.

“We hope this sends a message to other NPEs, litigation finance companies, and their contingency law firms. OMNIVISION will not waver from its principles,” said Mr. Cleary. Defending against baseless NPE lawsuits is an investment for OMNIVISION, and the return on that investment is a growing reputation in the industry. Seeing that OMNIVISION will not be bullied by baseless threats, NPEs are significantly less likely to file nuisance infringement litigation against OMNIVISION.

OMNIVISION’s latest decisive NPE victory comes after nearly twelve months of litigation in the U.S. District Court for the Central District of California. The litigation was led by David Bluestone, Samuel Ruggio, and Charles McMahon of Benesch Friedlander Coplan & Aronoff LLP, along with Salil Bali from Stradling Yocca Carlson & Rauth LLP. VisionX Technologies, LLC was represented by One LLP and Farjami & Farjami LLP.

About OMNIVISION

OMNIVISION is a global fabless semiconductor organization that develops advanced digital imaging, analog and touch & display solutions for multiple applications and industries, including mobile phones; security and surveillance; automotive; computing; medical; and emerging applications. Its award-winning innovative technologies enable a smoother human/machine interface in many of today’s commercial devices. Find out more at www.ovt.com.

OMNIVISION® and the OMNIVISION logo are trademarks or registered trademarks of OMNIVISION. All other trademarks are the property of their respective owners.

Contacts

OMNIVISION Media Contact:
Sandy Fewkes

Kiterocket
+1 408.529.9685
sfewkes@kiterocket.com

OMNIVISION Company Contact:
DeAnn Liu
OMNIVISION
+1 408.916.2536
deann.liu@ovt.com

OMNIVISION


Release Versions

Contacts

OMNIVISION Media Contact:
Sandy Fewkes

Kiterocket
+1 408.529.9685
sfewkes@kiterocket.com

OMNIVISION Company Contact:
DeAnn Liu
OMNIVISION
+1 408.916.2536
deann.liu@ovt.com

Social Media Profiles
More News From OMNIVISION

OMNIVISION Partners with Biotech Dental to Develop Highly Accurate 3D Intraoral Scanners

SANTA CLARA, Calif. & SALON-DE-PROVENCE, France--(BUSINESS WIRE)--OMNIVISION, a leading global developer of semiconductor technology, including advanced digital imaging, analog, and display solutions, and Biotech Dental, a specialist in the design and manufacture of medical devices and digital solutions for dental applications, today announced a partnership that involves Biotech Dental’s use of multiple medical grade camera modules from OMNIVISION in the design of its new Scan4All 3D intraoral...

OMNIVISION Debuts Industry’s Smallest-Footprint Sensor for Presence Detection, Facial Recognition and Always-On

SANTA CLARA, Calif.--(BUSINESS WIRE)--OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog, and touch & display technology, today announced the new OV0TA1B monochrome (mono)/infrared (IR) CMOS image sensor, the first and only solution that fits 3mm module Y dimension and smaller notebook computers, webcams and IoT devices. The OV0TA1B is a low-power device that is ideal for artificial intelligence (AI)-based human presence detection (...

OMNIVISION Partners with Philips on Industry’s First In-Cabin Driver Health Monitoring Automotive Solution

BARCELONA, Spain--(BUSINESS WIRE)--OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, and Philips, a global technology company focused on improving people’s health and well-being through meaningful innovation in healthcare and consumer lifestyle, today announced they will jointly demonstrate a prototype of the world’s first in-cabin connected well-being monitoring solution at AutoSens Europe, taking p...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.